|1.||Sancho, Pilar: 6 articles (07/2014 - 09/2003)|
|2.||Nieto, Elena: 4 articles (07/2014 - 10/2005)|
|3.||Galeano, Eva: 4 articles (07/2014 - 10/2005)|
|4.||García-Pérez, Ana Isabel: 3 articles (07/2007 - 09/2003)|
|5.||García-Pérez, Ana I: 2 articles (07/2014 - 10/2011)|
|6.||Delgado, M Dolores: 2 articles (07/2007 - 10/2005)|
|7.||Pinilla, Montserrat: 2 articles (10/2005 - 09/2003)|
|8.||Graf, Federico: 2 articles (01/2002 - 01/2002)|
|9.||Della Casa, Vera: 2 articles (01/2002 - 01/2002)|
|10.||Pohlig, Gabriele: 2 articles (01/2002 - 01/2002)|
08/01/1987 - "Dequalinium is more effective than seven of eight established anticancer drugs in prolonging the survival of mice with intraperitoneally implanted mouse bladder carcinoma MB49. "
10/01/2005 - "Dequalinium (DQA) is a delocalized lipophylic cation that selectively targets the mitochondria of carcinoma cells. "
07/30/2003 - "Combination treatment employing a constant concentration (1.25 microM) of the DLC dequalinium chloride (DECA) plus varying concentrations of AZT (0-50 microM) enhanced the AZT-induced cytotoxicity of carcinoma cells at least fourfold for MCF-7 and CX-1 cells (IC50 at 5 microM AZT), and twofold for DU-145 cells (IC50 at 11 microM AZT). "
11/25/1998 - "Treatment of cultured human cervical carcinoma cells with the anticancer drug dequalinium (DEQ) was found to cause a delayed inhibition of cell growth. "
02/01/1998 - "Based on the intrinsic properties of dequalinium such as the in vivo selectivity for carcinoma cells and selective accumulation in mitochondria we propose DQAsomes as a novel and unique drug and gene delivery system."
01/01/2012 - "To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin®) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV). "
01/01/2002 - "In view of its wide antimicrobial spectrum dequalinium chloride is an efficient alternative in the local therapy of vaginal infections such as fluor vaginalis, bacterial vaginosis, aerobic vaginitis, vulvo-vaginal candidiasis and trichomoniasis."
01/01/2012 - "A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety."
10/25/1958 - "Trial of dequalinium for skin infections."
01/01/2002 - "Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections."
11/27/1965 - "[The use of dequalinium in sinus infections]."
12/01/1960 - "Clinical evaluation of Dequadin in the treatment of vaginal infections & infestations."
12/01/1958 - "Clinical evaluation of dequadin in the treatment of vaginal infections & infestations."
|4.||Mycoses (Diseases, Fungus)
07/01/2007 - "Dequalinium (DQA) has been proposed as a selective antitumoral agent due to its preferential accumulation in mitochondria of cancer cells. "
11/01/1986 - "At sublethal doses, dequalinium chloride significantly inhibited primary tumor growth to 60% that of controls and recurrent tumor growth to 50% that of controls. "
11/01/1986 - "Inhibition of rat colon tumor isograft growth with dequalinium chloride."
05/01/2014 - "Delocalized lipophilic cations, such as dequalinium (DQA), are accumulated in cancer cells attracted by the highly negative mitochondrial transmembrane potential of these cells. "
01/23/1998 - "1,1'-Decamethylenebis-4-aminoquinaldinium diiodide (DECA; dequalinium) is an anti-tumor agent and protein kinase C (PKC) inhibitor whose mechanism of action with PKC is unknown. "
|3.||Polyethylene Glycols (Polyethylene Glycol)
|6.||Vaginal Creams, Foams, and Jellies (Vaginal Tablet)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
|10.||Protein Kinases (Protein Kinase)
|2.||Boron Neutron Capture Therapy
|4.||Dilatation and Curettage (D&C)